NSE
Medico Remedies LimitedMEDICO
Medico Remedies Limited is an NSE-listed company (MEDICO).
AI-generated overview — verify before relying on it.
Net institutional flow
+₹20.6 Cr
Institutional buyers
4 in / 2 out
High-impact filings
0 · tilt Neutral
Next corporate action
—
Competitive landscape — the read
vs most-traded names| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | MTNL | +₹41.3 Cr | 331 | — | — | — | — |
| 2 | MEDICOThis | +₹20.6 Cr | 48 | — | — | — | — |
| 3 | ATALREAL | +₹7.4 Cr | 363 | — | — | — | — |
| 4 | GATECH | +₹0.4 Cr | 298 | — | — | — | — |
| 5 | IRMENERGY | −₹2.2 Cr | 356 | — | — | — | — |
| 6 | QUADFUTURE | −₹9 Cr | 571 | — | — | — | — |
| 7 | MOBIKWIK | −₹150.9 Cr | 975 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
Timeline — MEDICO day by day
- 2026-03-27BulkBUY · ₹14.4 CrR G FAMILY TRUST
- 2026-03-27BulkSELL · ₹14.4 CrRG HUF
- 2026-03-25BulkBUY · ₹5.3 CrR G FAMILY TRUST
- 2026-03-25BulkSELL · ₹5.3 CrRAVI GOYAL (HUF)
Merged from deals, filings, corporate actions and news — newest first. Scope the deal/action portion with the period chips below.
Filings that matter
No scored filings for MEDICO yet.
4 deals · 2026-03-25 → 2026-03-27
| Date | Counterparty | Investor type | Side | Value |
|---|---|---|---|---|
| 2026-03-27 | R G FAMILY TRUST | Institution | BUY | ₹14.4 Cr |
| 2026-03-27 | RG HUF | HNI / other | SELL | ₹14.4 Cr |
| 2026-03-25 | R G FAMILY TRUST | Institution | BUY | ₹5.3 Cr |
| 2026-03-25 | RAVI GOYAL (HUF) | HNI / other | SELL | ₹5.3 Cr |
4 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
News & chatter on MEDICO
RSS News
0No recent news.
Google News RSS — links open the source.
The Dispatch
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.